文献速递肝病

非酒精性脂肪性肝病患者的肝脏相关事件与肝外事件:一项回顾性竞争风险分析

Liver-related and extrahepatic events in patients with non-alcoholic fatty liver disease: a retrospective competing risks analysis.
PubMed 文献 · Aliment Pharmacol Ther · 2022-01-05

观察累积发生率函数显示,F0-F1、F2和F3-F4患者的60个月LRE概率分别为0.2%、2%和9.7%,EHE概率分别为3%、3.8%和6.4%。结论认为EHE的可能性与肝纤维化严重程度相关并随其增加,而LRE风险在F0-F1可忽略、F2低但具临床意义、F3-F4高。

要点

  • F0-F1患者60个月LRE概率0.2%、EHE概率3%;F2患者分别为2%和3.8%;F3-F4患者分别为9.7%和6.4%。
  • F0-F1和F2患者中,年龄>50岁(HR 2.7)是LRE唯一预测因素;EHE独立危险因素包括年龄>50岁(HR 2.96)、既往心血管事件(HR 2.07)和既往肝外癌症(HR 2.36)。
  • F3-F4患者中,LRE相关因素包括年龄>55岁(HR 1.73)、肥胖(HR 1.52)、血小板<150 000/mmc(HR 3.66)和log(GGT)(HR 1.77);EHE独立预测因素为年龄>55岁(HR 1.74)和既往心血管事件(HR 2.51)。

核心结论

  • NAFLD患者EHE的可能性具有临床相关性,并随肝纤维化严重程度增加而升高;LRE风险在F0-F1可忽略、F2低但具临床意义、F3-F4高。

主要发现

  • 观察累积发生率函数显示,F0-F1患者60个月LRE和EHE概率分别为0.2%和3%,F2患者分别为2%和3.8%,F3-F4患者分别为9.7%和6.4%。
  • F0-F1和F2患者中,年龄>50岁(HR 2.7)是LRE唯一预测因素;EHE独立危险因素包括年龄>50岁(HR 2.96)、既往心血管事件(HR 2.07)和既往肝外癌症(HR 2.36)。
  • F3-F4患者中,LRE相关因素包括年龄>55岁(HR 1.73)、肥胖(HR 1.52)、血小板<150 000/mmc(HR 3.66)和log(GGT)(HR 1.77);EHE独立预测因素为年龄>55岁(HR 1.74)和既往心血管事件(HR 2.51)。
  • 预测累积发生率函数在F0-F1、F2和F3-F4患者中对事件风险进行了分层,结果在外部复制队列中得到验证。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND & AIM: Non-alcoholic fatty liver disease (NAFLD), and especially fibrotic non-alcoholic steatohepatitis, is associated with high risks of liver-related events (LRE) and extrahepatic events (EHE). We evaluated the competitive risk occurrence of LRE and EHE in a large cohort of biopsy-proven NAFLD stratified according to baseline severity of fibrosis. METHODS: Two thousand one hundred thirty-five patients with biopsy-proven NAFLD were enrolled. Observed cumulative incidence functions (CIFs) were used to evaluate the risk of LRE and EHE; cause-specific Cox model and predicted CIFs were fitted to identify predictors of LRE and EHE. A replication cohort of NAFLD patients with liver fibrosis severity estimated by liver stiffness measurement by transient elastography was also enrolled. RESULTS: Observed CIFs indicated that the 60-month probabilities of LRE and EHE were 0.2% and 3% in F0-F1, 2% and 3.8% in F2 and 9.7% and 6.4% in F3-F4 patients, respectively. The cause-specific Cox model indicated that in F0-F1 and F2 patients, age > 50 years (HR 2.7) was the only predictor of LRE, while age > 50 years (HR 2.96), previous cardiovascular events (CVE, HR 2.07), and previous extra-hepatic cancer (HR 2.36) were independent risk factors for EHE. In F3-F4 patients, age > 55 years (HR 1.73), obesity (HR 1.52), PLT < 150 000/mmc (HR 3.66) and log(GGT) (HR 1.77) were associated with LRE, while age > 55 years (HR 1.74) and previous CVE (HR 2.51) were independent predictors of EHE. Predicted CIFs for HE and EHE in F0-F1, F2 and F3-F4 patients stratified the risk of events. The results were externally replicated. CONCLUSION: The likelihood of EHE in NAFLD patients is relevant and increases according to the severity of liver fibrosis, while the risk of LRE is negligible in F0-F1, low but clinically relevant in F2 and high in F3-F4 patients.

来源:Aliment Pharmacol Ther,查看原文。版权归原作者所有。

引用

  1. Pennisi G, Enea M, Romero-Gomez M, et al. Liver-related and extrahepatic events in patients with non-alcoholic fatty liver disease: a retrospective competing risks analysis. Aliment Pharmacol Ther. 2022. PMID: 34988994. doi:10.1111/apt.16763

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。